TCRX · TScan Therapeutics, Inc.

NasdaqHealthcareBiotechnology

Tscan Therapeutics Inc Is A Fully Integrated Clinical-Stage Biotechnology Company Focused On Developing A Robust Pipeline Of T Cell Receptor (Tcr)-Engineered T Cell, Or Tcr-T, Therapies For The Treatment Of Patients With Cancer. The Company'S Liquid Tumor Tcr-T Therapy Candidates, Tsc-100 And Tsc-101, Are In Development For The Treatment Of Patients With Hematologic Malignancies To Eliminate Residual Leukemia And Prevent Relapse After Hematopoietic Stem Cell Transplantation. It Is Also Developing Multiplexed Tcr-T Therapy Candidates For The Treatment Of Various Solid Tumors.

HealthcareNasdaqUS

FLOAT

55.3M

FREE FLOAT %

87%

SHARES O/S

63.5M

MARKET CAP

$13.8M

EXCHANGE

Nasdaq

COUNTRY

TCRX Catalyst History

No catalysts recorded for TCRX yet

Day Trader Sniper hasn't classified a publishable catalyst for TCRX yet. New events appear here as they're scored.

Be early on the next TCRX spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

TCRX · TScan Therapeutics, Inc.

TCRX Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.